These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18520172)

  • 1. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y
    Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [One point message of PG-MARJ 2005 (Allergic Rhinitis) treatment of Japanese cedar pollinosis].
    Konno A
    Arerugi; 2008 Jul; 57(7):817-23. PubMed ID: 18688181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prophylactic and therapeutic vaccines for Japanese cedar pollinosis].
    Ishii Y
    Nihon Yakurigaku Zasshi; 2010 Jun; 135(6):250-3. PubMed ID: 20543516
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
    Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
    Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
    [No Abstract]   [Full Text] [Related]  

  • 6. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical study of Japanese cedar (Cryptomeria japonica) pollen-induced asthma.
    Maeda Y; Akiyama K; Shida T
    Allergol Int; 2008 Dec; 57(4):413-7. PubMed ID: 18946237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance and methods of allergen immunotherapy for pollinosis].
    Ohkubo K
    Arerugi; 2008 Feb; 57(2):73-8. PubMed ID: 18349580
    [No Abstract]   [Full Text] [Related]  

  • 9. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
    Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
    Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
    Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
    Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
    [No Abstract]   [Full Text] [Related]  

  • 11. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of nasal blockage in a Japanese cedar pollen-induced allergic rhinitis model mouse.
    Ogita-Nakanishi H; Nabe T; Mizutani N; Fujii M; Kohno S
    Allergol Int; 2009 Jun; 58(2):171-8. PubMed ID: 19240378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
    Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy.
    Frew AJ
    N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y; Takahashi Y; Fujita T; Fukuyama S
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation.
    Hsiao KC; Smart J
    Pediatr Allergy Immunol; 2014 Nov; 25(7):714-5. PubMed ID: 25200920
    [No Abstract]   [Full Text] [Related]  

  • 18. Sublingual immunotherapy: allergen specific or placebo effect?
    Kette F; Smith W
    J Allergy Clin Immunol; 2011 Aug; 128(2):430; author reply 430-2. PubMed ID: 21665261
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylaxis to multiple pollen allergen sublingual immunotherapy.
    Eifan AO; Keles S; Bahceciler NN; Barlan IB
    Allergy; 2007 May; 62(5):567-8. PubMed ID: 17313400
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of efficacy for Japanese cedar pollen-specific immunotherapy by lymphocyte proliferation test].
    Imai T; Nohara O; Katayama N; Endo T; Inoue S; Sakaguchi M; Taniguchi Y; Nakagawa T; Saito S
    Arerugi; 1996 Nov; 45(11):1172-80. PubMed ID: 8990529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.